Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Sector news
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Real-time Estimate Cboe Europe  -  06:19 2022-12-05 am EST
85.21 CHF   +1.27%
04:56aStifel Upgrades Recommendation on Novartis to Buy From Hold
MT
01:42aNovartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
01:36aNovartis' Prostate Cancer Drug Extends Progression-free Survival In Late-stage Study
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
12/02Insider Sell: Johnson & Johnson
MT
12/02Pfizer to Spend More Than $2.5 Billion to Expand Plants in Belgium, Ireland
MT
12/02Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints
MT
12/02Pfizer Plans EUR1.2 Billion Investment in Belgium
MT
12/02MT Hoejgaard Wins DKK600 Million Contract to Build New Factory for Novo Nordisk
MT
12/02Rigel Pharmaceuticals Shares Leap Premarket on FDA OK of Rezlidhia
DJ
12/02Sanofi Says Any Potential Offer for Horizon Therapeutics Will Be Made in Cash
MT
12/01Transcript : Pfizer Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe..
CI
12/01Strong Eurozone Manufacturing Data Pushes European Bourses to Close Mostly Higher
MT
12/01Global markets live: General Electric, Tesla, Apple, Salesforce, Boe..
MS
12/01Eli Lilly and Co.'s Unit Completes Negotiations With Canadian Drug Accessibility Allian..
MT
12/01Pfizer Aims to Double Production at Dublin Plant With 1.2 Billion-Euro Investment
MT
12/01Transcript : AbbVie Inc. Presents at Piper Sandler 34th Annual Healthcare Con..
CI
12/01Morgan Stanley Adjusts Price Target on Johnson & Johnson to $178 From $170, Maintains E..
MT
12/01Lilly Wraps Up Acquisition of Akouos
MT
12/01Roivant Sciences Launches Subsidiary With Pfizer to Develop Drug Candidate for Inflamma..
MT
12/01Roivant Sciences and Pfizer Forms New Vant Company Focused on Developing TL1A Drug Cand..
CI
12/01Abbvie Inc. Announces Provincial Reimbursement for RINVOQ (Upadacitinib) for the Treatm..
CI
12/01Pfizer, Valneva Say Lyme Disease Vaccine Candidate Shows Antibody Levels Remain Above B..
MT
12/01Eli Lilly Says Phase 3 Study of Alzheimer's Disease Drug Candidate Meets All Endpoints
MT
12/01Valneva, Pfizer Tout Six-month Antibody Persistence Data for Lyme Disease Vaccine Candi..
MT
12/01Valneva-Pfizer's Lyme Disease Jab Continues To Provide Protection Six Months Post-vacci..
MT
12/01Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults fo..
CI
12/01Eli Lilly and Company (NYSE:LLY) completed the acquisition o..
CI
12/01Carrick Therapeutics, Ltd. announced that it has received $60 million in funding from a..
CI
11/30US FDA Cancels Emergency Use Approval For Eli Lilly's COVID-19 Treatment
MT
11/30Eli Lilly and Company Shares Positive Donanemab Data in First Active Comparator Study i..
CI
11/30Johnson & Johnson Chief Executive Joaquin Duato to Also Assume Chairman Role
MT
11/30Johnson & Johnson CEO Joaquin Duato to Become Chairman of the Board
DJ
11/30Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
CI
11/30Sector Update: Health Care Carried Higher by Surging Biotechs
MT
11/30FDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab
RE
11/30Eli Lilly's Bebtelovimab COVID-19 Drug Reportedly Paused by US FDA
MT
11/30FDA Pauses Authorization for Eli Lilly's Bebtelovimab COVID Drug
MT
11/30Sector Update: Health Care Stocks Still Struggling for Direction Wednesday..
MT
11/30Sector Update: Health Care
MT
11/30Transcript : Eli Lilly and Company Presents at 5th Annual Evercore ISI Health..
CI
11/30AC Immune Says Alzheimer's Vaccine Candidate Tapped for Further Development; Shares Ris..
MT
11/30Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing
MT
11/29Sanofi in Early Deal Talks with Horizon Therapeutics
MT
11/29Merck KGaA Enters Clinical Trial Partnership For Investigational Bladder Cancer Combo T..
MT
11/29Horizon Therapeutics Confirms 'Highly Preliminary Discussions' With Three Suitors -- Sh..
MT
11/29Eli Lilly Earnings, Revenue Set to Grow in 2023 With 'Modest' Impact From New Launches,..
MT
11/29Transcript : AbbVie Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe..
CI
11/29Immutep Signs Trial Collaboration, Supply Deal With Pfizer, Merck KGaA for Urothelial C..
MT
11/29Immutep Strikes Clinical Trial Collaboration with Merck, Pfizer for Urothelial Cancer T..
MT
11/28Immutep Enters second Collaboration with Pfizer and Merck KGaA
CI
11/28Strand Therapeutics Inc. announced that it has received $44.529393 million in funding f..
CI
11/25Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available
MT
11/25Elon Musk says Twitter's verified service with colors to start next week
RE
11/25NOVO NORDISK : Berenberg reaffirms its Neutral rating
MD
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/23European Commission Orders Treatment Courses Of Pfizer's COVID-19 Pill
MT
11/23Sector Update: Health Care Stocks Advancing Wednesday Afternoon
MT
11/23Sector Update: Health Care Stocks Still Advancing in Wednesday Trading
MT
11/23Sector Update: Health Care
MT
11/23Eurozone PMI Data Supports European Equities
MT
11/23Correction: Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stoc..
MT
11/23Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stock Futures Inch Higher ..
MT
11/23PFIZER INC : From Sell to Buy by Credit Suisse
MD
11/23Johnson & Johnson's Janssen Pharmaceutical Says Phase 3 Trial of Major Depressive Disor..
MT
11/23AbbVie Says European Commission Approves Skyrizi for Treatment of Crohn's Disease
MT
11/23AbbVie Announces European Commission Approval of SKYRIZI« (risankizumab) for the Treatm..
CI
11/22Australia's CSL prices hemophilia gene therapy at $3.5 million
RE
11/22CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-1..
MT
11/22Factbox-Pharmacies, drug companies settle lawsuits over U.S. opioid crisis
RE
11/22Teva, AbbVie finalize $6.6 billion U.S. opioid settlements
RE
11/22Teva, Allergan Finalize Terms of Nationwide Opioid Settlement -- Update
DJ
11/22Berenberg Bank Raises Eli Lilly and Co. PT to $375 From $345, Says Underlying Performan..
MT
11/22Arvinas, Inc. Announces Initial Results from Phase 2 Cohort Expansion Portion of Phase ..
CI
11/22Shionogi's Covid-19 Drug Gets Panel Approval in Japan
DJ
11/22Buying in Public Sector Bank Stocks Aids Indian Equities Snap Losing Run; IndusInd Bank..
MT
11/22Glenmark Pharmaceuticals Reaches Settlement with Pfizer Over Kidney Cancer Drug
MT
11/22Novo Nordisk Invests $743.6 Million to Expand Clinical Manufacturing Facilities
DJ
11/22Novo Nordisk to Spend $744 Million to Expand Clinical Active Pharma Ingredients Capacit..
MT
11/22Novo Nordisk Invests DKK 5.4 billion Danish Kroner in Expansion of Clinical Manufacturi..
CI
11/21Glenmark Pharmaceuticals Reaches Settlement Agreement with Pfizer for Axitinib Tablets,..
CI
11/21Novo Nordisk Agrees to $40 Million Milestone Payment to Prothena
MT
11/21Prothena Achieves $40 Million Clinical Milestone Payment From Novo Nordisk
DJ
11/21Insider Sell: Johnson & Johnson
MT
11/21AbbVie Says Epcoritamab Obtains FDA Priority Review for Treatment of Large B-Cell Lymph..
MT
11/21AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma
DJ
11/21AbbVie Inc. Announces Acceptance of Biologics License Application for Epcoritamab by U...
CI
11/21Aosaikang Pharma Wins Nod to Market Variant of Pfizer's Breast Cancer Drug
MT
11/18Pfizer's Updated Omicron Booster Shows Improved Immunity Against New Variants
MT
11/18Transcript : Pfizer Inc. Presents at 4th Annual Wolfe Research Healthcare Con..
CI
11/18Pfizer, BioNTech Says Bivalent COVID-19 Vaccine Shows 'Greater' Response
MT
11/18Credit Suisse Starts Eli Lilly at Outperform With $395 Price Target
MT
11/18Credit Suisse Starts AbbVie at Outperform With $170 Price Target
MT
11/18Credit Suisse Starts Johnson & Johnson at Neutral With $170 Price Target
MT
11/18Credit Suisse Starts Pfizer at Outperform With $55 Price Target
MT
11/18Pfizer, BioNTech Say Bivalent COVID-19 Booster Showed Improved Immune Response Against ..
MT
11/18Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults
RE
11/18Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demon..
CI
11/18Factbox-Twitter 2.0: Musk warns of bankruptcy, flip-flops on blue ch..
RE
11/18Factbox-Advertisers react to Twitter's new ownership
RE
11/18Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy,..
MS
11/18Big Pharma may have to reveal government deals in WHO's draft pandemic rules
RE
11/17CytomX Therapeutics Shares Rally on Regeneron Pact
DJ
11/17Morgan Stanley Slashes Price Target on Eli Lilly to $436 From $441, Affirms Overweight ..
MT